At Stallergenes Greer,
we partner with Health
Care Professionals for
patients to live a life
beyond allergy,
during and after
Allergen
Immunotherapy (AIT)
Go Inside Staloral
STALORAL is not registered in Singapore.
2023_072EN01_September 2023
Staloral® natural allergen
extracts mimic the diverse
real-life exposure of
respiratory allergic patients1-3
Highly potent, Staloral®
demonstrated early 1st results
and meaningful improvements
over time for patients to live
a life beyond allergy4
Staloral® is a fully customisable
sublingual immunotherapy solution
that optimises tolerability and
effectiveness for rhinitis patients
with or without controlled mild to
moderate asthma4-8
Staloral® has been evaluated in
over 30 studies and has proven
carry-over effects for up to 6 years after
treatment cessation, even preventing
allergy worsening8,9*
Let's see how
*Results compared with placebo, in a subpopulation of elderly (≥60
years of age) patients
“Hi I’m Sonke and I’m a P.E. teacher. The athletics and birch-pollen seasons overlap, this is when my students need me the most but my school work and ability to concentrate are impacted by my AR.​"
Treat him
The following medical history is fictional. The presentation is based on typically occurring
circumstances. The treatment and the success of the therapy depicted represent an idealized
course. This possible course of therapy has been confirmed by clinical studies. Nevertheless, each
patient and each course of disease is highly individual and a corresponding effect cannot be
expected and guaranteed for all patients.

45 years old German
male, P.E. Teacher

Divorced, 3 children,
pets (cats, dogs)

Specialized in athletics

Before
"I experience AR symptoms
exclusively during the birch-
pollen season. Additionally, I
have developed OAS, leading
to oral itching when I consume
celery and fruits like apples,
pears, and plums. To manage
my AR, I rely on significant
amounts of symptomatic
medication. However, I am
currently facing challenges in
adequately preparing my
students for the local Junior
Athletics Championship."​
Help him to live a life beyond allergy
Clinical History

For almost 15 years, he has been suffering
from violent itchy eyes and runny nose
from March to August with mild symptoms
in Autumn, he is particularly struggling
with symptoms control in March-April.

After a few years without treatment, he
received oral H1-antihistamine and
corticosteroids eye drops.

Later, he experiencedworsening of
rhinoconjunctivitis symptoms associated
with fatigue, headache and oral syndrome
(lip swelling, throat discomfort) when
eating apples and was dispensed oral
corticosteroids.

Clinical Exam

mild itchy eyes and
runny nose

no wheeze

Diagnosis
Diagnosis:
Allergic rhinitis to grass and
birch pollen with oral allergy
syndrome.
Birch pollen allergy associated
with the most bothersome
symptoms.
Treat
Physician
Recommendation
Symptomatic Treatment
Subcutaneous immunotherapy
Sublingual immunotherapy liquid formulation
Sublingual immunotherapy tablet formulation
Patient's Choice

Symptomatic
Treatment

Sublingual immunotherapy
liquid formulation

Initiate Treatment
Early results
“Yesterday, I spent the whole day with
my school colleagues in the park for
our annual BBQ end-of-school party, I
finally feel like I can achieve my full
potential in school and on the track
with my students!”
Maintenance
Maintained
Results
“It's a whole year since I finished
AIT and I just had the best ever
early summer holiday with my
children. We went camping and zip-
lining in the forest. On our way
back home, we're going to spend
some more days in the campsite
near the city where I was born. It's
really good that I don't have to be
worried as before about allergies
when I go outside so I can show
them the places I grew in as a kid.”
Life beyond allergy
Every patient
deserves to live a life
beyond allergy
Potential AIT benefits over time
Theoretical concept adapted from Spriggs K, et al (Eds). Fast Facts: Respiratory Allergies. 2021. Basel: S Karger AR.
Staloral® is a fully customisable
sublingual immunotherapy solution
that optimises tolerability and
effectiveness for rhinitis patients
with or without controlled mild to
moderate asthma4-8
Highly potent, Staloral® demonstrated
early 1st results and meaningful improvements over time for patients to live a life beyond allergy4
Staloral® has been evaluated
in over 30 studies and has
proven carry-over effects for
up to 6 years after treatment
cessation, even preventing
allergy worsening8,9*
Let us tell you all about it
*Results compared with placebo, in a subpopulation of elderly
(≥60 years of age) patients
STALORAL or STALORAL 300 is not registered in Singapore. It is registered in 22 countries (11 countries in European Union (Bulgaria, Czech Republic, Germany, Hungary, Latvia, Lithuania, Luxembourg, Poland, Romania, Slovakia, Slovenia) and in Algeria, Jordan, Korea (South), Lebanon, Morocco, Russia, Saudi Arabia, Switzerland, Syria, Tunisia and United Arab Emirates). … Read more Read less